Investments in Basic Research for Pediatric Cancers: Developing Dinutuximab

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

NCI makes substantial investments in basic research, recognizing its fundamental importance in unraveling the complexities of pediatric cancers. A deeper understanding of cancer leads to new approaches for cancer prevention, screening, and treatment, like dinutuximab to treat neuroblastoma. Learn more about basic research in NCI’s Role in Cancer Research.